Godavari Drugs Ltd

Board approval and filing status

• Board approved the deviation/variation in utilisation of funds.
• Statement filed with the Stock Exchange.

Quarterly results snapshot

• Revenue from operations: 2,795.72 Lakhs; YoY up from 2,381.13 Lakhs.
• Total revenue from operations: 2,810.82 Lakhs; YoY up from 2,382.35 Lakhs.
• Net profit for the period: 110.91 Lakhs; YoY up from 104.06 Lakhs.
• EPS (Basic and Diluted): 1.10 Rs; prior-year quarter 1.38 Rs.
• Board approved and took on record the results on Aug 14, 2026.
• EPS for current quarter based on paid-up capital of 1,012.74 Lakhs vs 753.05 Lakhs as of 30.06.2025.
• Exceptional items: 0 in quarter; 10.38 in Q4 FY26.

Key approvals and financials

• Un-audited quarterly financial results for quarter ended 30.06.2026 approved.
• Limited Review Report for quarter ended 30.06.2026 approved.
• Allotment of equity shares on conversion of 7,86,690 warrants into equity shares approved.
• Equity shares allotted on conversion at Rs 89 per share, including premium Rs 10.
• Total amount receivable from allottees: Rs 5,25,11,557.50 (75% of issue price).
• Post-conversion paid-up capital increased to Rs 10,91,41,250 comprising 1,09,14,125 shares.
• Promoter-category allottees listed in Annexure A (7,86,690 shares).
• Disclosure under Regulation 30 of SEBI LODR enclosed (Annexure-B).
• Results reviewed by Audit Committee and approved by the Board.
• Q1 2026 revenue from operations Rs 2,795.72 lakh; total revenue Rs 2,810.82 lakh.
• Net profit for the quarter Rs 110.91 lakh; basic EPS Rs 1.10.

Meeting Details

• Board meeting on 14 August 2026 to consider unaudited Q1 results for the quarter ended 30 June 2026.

Other Notes

• Corrigendum correcting the meeting date to 14 August 2026; agenda unchanged.

Meeting Details

• Date: 24 August 2026.
• Time: Not disclosed.
• Location: Not disclosed.

Key Agenda Items

• Unaudited Q1 FY2026 results with Limited Review Report (quarter ended 30 June 2026).
• Any other business with the chair's permission.

Processing status

• Dematerialisation requests for quarter ended 30 June 2026 were confirmed to the Depositories.
• Securities dematerialised have been listed on the exchanges where earlier issued securities are listed.
• Physical certificates received for dematerialisation were mutilated and cancelled after due verification.
• Depository's name was substituted as registered owner in the Register of Members within the prescribed period.